7999 related articles for article (PubMed ID: 10605300)
1. Hypofractionated radiation therapy in the modern era.
Graham MV
Rays; 1999; 24(3):400-5. PubMed ID: 10605300
[TBL] [Abstract][Full Text] [Related]
2. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
3. Exploring the possibility of unique molecular, biological, and tissue effects with hypofractionated radiotherapy.
Story M; Kodym R; Saha D
Semin Radiat Oncol; 2008 Oct; 18(4):244-8. PubMed ID: 18725111
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for Bowen's disease of the skin.
Lukas VanderSpek LA; Pond GR; Wells W; Tsang RW
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):505-10. PubMed ID: 16168842
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
6. [Role of radiotherapy in combined therapy of soft tissue sarcoma in children and adolescents].
Golubicić I; Nikitović M; Bokun J; Gavrilović D; Radosević-Jelić Lj
Srp Arh Celok Lek; 2000; 128(5-6):172-8. PubMed ID: 11089417
[TBL] [Abstract][Full Text] [Related]
7. Head and neck squamous cell carcinoma: optimizing the therapeutic index.
Rosenthal DI; Blanco AI
Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957
[TBL] [Abstract][Full Text] [Related]
8. A review of hypofractionated palliative radiotherapy.
Lutz ST; Chow EL; Hartsell WF; Konski AA
Cancer; 2007 Apr; 109(8):1462-70. PubMed ID: 17330854
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of hypofractionated radiotherapy and conventional fractionated radiotherapy in the management of carcinoma of the cervix in Ibadan, Nigeria.
Campbell OB; Akinlade IB; Arowojolu A; Babarinsa IA; Agwimah RI; Adewole IF
Afr J Med Med Sci; 2000; 29(3-4):253-8. PubMed ID: 11714001
[TBL] [Abstract][Full Text] [Related]
11. Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology.
Teh BS; Woo SY; Butler EB
Oncologist; 1999; 4(6):433-42. PubMed ID: 10631687
[TBL] [Abstract][Full Text] [Related]
12. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
[TBL] [Abstract][Full Text] [Related]
13. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
Paganetti H
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
[TBL] [Abstract][Full Text] [Related]
16. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial.
Yeoh EE; Holloway RH; Fraser RJ; Botten RJ; Di Matteo AC; Butters J; Weerasinghe S; Abeysinghe P
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1072-83. PubMed ID: 16965866
[TBL] [Abstract][Full Text] [Related]
18. The state of the art in radiation therapy.
Hogle WP
Semin Oncol Nurs; 2006 Nov; 22(4):212-20. PubMed ID: 17095397
[TBL] [Abstract][Full Text] [Related]
19. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
20. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma.
Olivier KR; Schild SE; Morris CG; Brown PD; Markovic SN
Cancer; 2007 Oct; 110(8):1791-5. PubMed ID: 17721993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]